Abstract
The general use of carbamazepine in psychiatry is briefly surveyed. It is concluded that carbamazepine has clinical efficacy in patients suffering from various psychiatric syndromes. The compound is probably most effective in diseases with an episodic course, e.g. psychiatric syndromes associated with focalizations of paroxysmal EEG activity, affective disorders, and certain paroxysmal or arrhythmic syndromes. The clinical picture of the disorders responding to carbamazepine treatment may mimic paranoid psychosis, schizophrenia, or manic-depressive psychosis. Clinical guidelines are provided for carbamazepine treatment in psychiatry. Monitoring of the serum drug concentrations is recommended to check patient compliance and avoid toxic concentrations.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
